Antithrombin Market to Attract a Revenue of US $704.5 Million by 2025 Globally: Transparency Market Research

ALBANY, New York, October 17, 2017 /PRNewswire/ --

"Antithrombotic drugs help in the prevention of thrombus by mimicking the role of antithrombin," says a TMR analyst. Antithrombin a small protein produced in the body has significance for blood clotting. It also has significance for inactivation of several enzymes in the coagulation system. On the other hand, commercially available antithrombin derived from human plasma and genetic recombination that are available in a few variants are indicated for hereditary thrombophilia as a line of treatment for congenital antithrombin deficiency.

As per estimates presented in a report by TMR, the demand global antithrombin market will rise at a CAGR of 5.2% for the forecast period of 2017 to 2025. The market for antithrombin is predicted to attract a revenue of US$704.5 mn by the end of 2025 from US$448.2 mn in 2016.

View Full Report at https://www.transparencymarketresearch.com/antithrombin-market.html

The antithrombin market is primarily driven by the widespread use of antithrombin for several medical conditions such as hereditary antithrombin deficiency, extracorporeal membrane oxygenation (ECMO), disseminated intravascular coagulation (DIC), and sepsis.

Apart from this, engineered antithrombin has gained clinical significance lately for the prevention of various peripartum and perioperative thromboembolic events or blood clots.

Request to View Sample Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4500

Rising prevalence of hereditary antithrombin deficiency and rising antithrombin treatment among adults for ECMO is expected to provide impetus to the antithrombin market globally during the forecast period. The increasing use of antithrombin in combination with heparin is likely to support the growth of antithrombin market. For instance, heparin resistance in cardiac surgery is likely to create opportunities for use of antithrombin products in anticoagulation therapy.

On the downside, price concerns of antithrombin over substitutes could hamper the growth of global antithrombin market. In particular, pricing pressures in countries in Asia Pacific and Europe could hamper adoption of antithrombin therapy, as antithrombin is considered to be an expensive treatment with few returns.

Request to download and view full ToC - https://www.transparencymarketresearch.com/report-toc/4500

The global Antithrombin market is consolidated in nature with a few small-scale vendors that operate in regional markets and a few large-scale vendors that operate in international markets, states a report by Transparency Market Research (TMR). In the coming years, the market is likely to witness the entry of new participants, as a result of which competition in the market is predicted to heat up.

However, some of the companies such as Grifols, Shire Plc., and rEVO Biologics Inc. dominate the market holding leading market shares. CSL Limited, Kedrion S.p.A, Lee Bisolutions, and Scripps Laboratories Inc. are some other prominent participants in the global antithrombin market. These market players are engaged in research and development in order to accentuate their respective market shares.

Global Antithrombin Market Report is available @ US$ 5795 [https://www.transparencymarketresearch.com/checkout.php?rep_id=4500&ltype=S ]

About TMR 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

        

        Contact 
        Transparency Market Research 
        State Tower 
        90 State Street, 
        Suite 700, 
        Albany NY - 12207 
        United States 
        Tel: +1-518-618-1030 
        USA - Canada Toll Free: 866-552-3453 
        Email: sales@transparencymarketresearch.com 

 

Website: http://www.transparencymarketresearch.com TMR Blog: http://www.theglobalhealthnews.com

SOURCE Transparency Market Research